106 related articles for article (PubMed ID: 3004140)
1. Aza-substituted omega-side-chain modifications of 7-oxabicyclo[2.2.1]heptane thromboxane A2 receptor antagonists: structure-activity relationships.
Nakane M; Reid JA; Haslanger MF; Garber DP; Harris DN; Ogletree ML; Greenberg R
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():291-3. PubMed ID: 3004140
[No Abstract] [Full Text] [Related]
2. Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
Sprague PW; Heikes JE; Harris DN; Greenberg R
Adv Prostaglandin Thromboxane Res; 1980; 6():493-6. PubMed ID: 7189952
[No Abstract] [Full Text] [Related]
3. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
Sprague PW; Heikes JE; Harris DN; Greenberg R
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
[No Abstract] [Full Text] [Related]
4. Characterization of thromboxane receptors in human platelets.
Jones RL; Wilson NH; Armstrong RA
Adv Exp Med Biol; 1985; 192():67-81. PubMed ID: 3010674
[No Abstract] [Full Text] [Related]
5. Synthesis of thromboxane receptor antagonists with bicyclo[3.1.0]hexane ring systems.
Kamata S; Haga N; Tsuri T; Uchida K; Kakushi H; Arita H; Hanasaki K
J Med Chem; 1990 Jan; 33(1):229-39. PubMed ID: 2136917
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of 5,6-exo-epoxy-7-oxabicyclo[2.2.1]heptane derivatives.
Das J; Vu T; Harris DN; Ogletree ML
J Med Chem; 1988 May; 31(5):930-5. PubMed ID: 2966247
[TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane A2 receptor antagonists. II. Synthesis and pharmacological activity of 6,6-dimethylbicyclo[3.1.1]heptane derivatives with the benzenesulfonylamino group.
Seno K; Hagishita S
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):948-54. PubMed ID: 2527624
[TBL] [Abstract][Full Text] [Related]
9. Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
Haslanger MF; Sprague PW; Snitman D; Vu T; Harris DN; Greenberg R; Powell J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():293-7. PubMed ID: 6221540
[No Abstract] [Full Text] [Related]
10. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
Gorman RR
Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
[No Abstract] [Full Text] [Related]
12. Prostaglandin endoperoxide and thromboxane A2 analogs.
Wilson NH; Jones RL
Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():393-425. PubMed ID: 2992245
[No Abstract] [Full Text] [Related]
13. Blockade of thromboxane and the prevention of eicosanoid-induced sudden death in mice.
Darius H; Lefer AM
Proc Soc Exp Biol Med; 1985 Nov; 180(2):364-8. PubMed ID: 2996012
[TBL] [Abstract][Full Text] [Related]
14. The effect of inhaled anesthetics on the platelet aggregation and the ligand-binding affinity of the platelet thromboxane A2 receptor.
Hirakata H; Ushikubi F; Narumiya S; Hatano Y; Nakamura K; Mori K
Anesth Analg; 1995 Jul; 81(1):114-8. PubMed ID: 7598237
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
[TBL] [Abstract][Full Text] [Related]
16. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
17. Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists.
Misra RN; Brown BR; Sher PM; Patel MM; Hall SE; Han WC; Barrish JC; Kocy O; Harris DN; Goldenberg HJ
J Med Chem; 1993 May; 36(10):1401-17. PubMed ID: 8496908
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2 receptor antagonists. III. Synthesis and pharmacological activity of 6,6-dimethylbicyclo[3.1.1]heptane derivatives with a substituted sulfonylamino group at C-2.
Seno K; Hagishita S
Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1524-33. PubMed ID: 2528414
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro activity of stereoisomers of a novel thromboxane receptor antagonist, (+-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo [2.2.1]hept-2-exo-yl]heptenoic acid.
Ohtani M; Narisada M
J Med Chem; 1990 Mar; 33(3):1027-31. PubMed ID: 2137879
[TBL] [Abstract][Full Text] [Related]
20. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
Carter AJ; Heptinstall S
Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
